4.6 Review

Therapeutic Implications of miRNAs for Muscle-Wasting Conditions

期刊

CELLS
卷 10, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/cells10113035

关键词

skeletal muscle regeneration; miRNAs; stem cells; epigenetics; inflammation; muscle injury; muscular dystrophies; cancer cachexia; sarcopenia; RNA; exosomes

资金

  1. INTERREG-Euregio Meuse-Rhine (GYM-Generate your muscle) [2020-EMR116]
  2. FWO [G0D4517N]
  3. Rondoufonds voor Duchenne Onderzoek [EQQ-FODUCHO2010]
  4. C1-KUL3DMUSYC [C14/17/111]

向作者/读者索取更多资源

miRNAs play a crucial role in muscle-wasting conditions, are associated with pathophysiological conditions, and have potential as diagnostic, prognostic, and therapeutic biomarkers.
MicroRNAs (miRNAs) are small, non-coding RNA molecules that are mainly involved in translational repression by binding to specific messenger RNAs. Recently, miRNAs have emerged as biomarkers, relevant for a multitude of pathophysiological conditions, and cells can selectively sort miRNAs into extracellular vesicles for paracrine and endocrine effects. In the overall context of muscle-wasting conditions, a multitude of miRNAs has been implied as being responsible for the typical dysregulation of anabolic and catabolic pathways. In general, chronic muscle disorders are associated with the main characteristic of a substantial loss in muscle mass. Muscular dystrophies (MDs) are a group of genetic diseases that cause muscle weakness and degeneration. Typically, MDs are caused by mutations in those genes responsible for upholding the integrity of muscle structure and function. Recently, the dysregulation of miRNA levels in such pathological conditions has been reported. This revelation is imperative for both MDs and other muscle-wasting conditions, such as sarcopenia and cancer cachexia. The expression levels of miRNAs have immense potential for use as potential diagnostic, prognostic and therapeutic biomarkers. Understanding the role of miRNAs in muscle-wasting conditions may lead to the development of novel strategies for the improvement of patient management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell & Tissue Engineering

Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation

Leo Machado, Perla Geara, Jordi Camps, Matthieu Dos Santos, Fatima Teixeira-Clerc, Jens Van Herck, Hugo Varet, Rachel Legendre, Jean-Michel Pawlotsky, Maurilio Sampaolesi, Thierry Voet, Pascal Maire, Frederic Relaix, Philippos Mourikis

Summary: Tissue damage alters cell-microenvironment interactions, influencing cells' responses. Muscle stem cell activation after injury serves as a paradigm of cell activation, while a broadly conserved stress response is shared across different cell types.

CELL STEM CELL (2021)

Article Endocrinology & Metabolism

Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age

Fabiola Marino, Mariangela Scalise, Nadia Salerno, Luca Salerno, Claudia Molinaro, Donato Cappetta, Michele Torella, Marta Greco, Daniela Foti, Ferdinando C. Sasso, Pasquale Mastroroberto, Antonella De Angelis, Georgina M. Ellison-Hughes, Maurilio Sampaolesi, Marcello Rota, Francesco Rossi, Konrad Urbanek, Bernardo Nadal-Ginard, Daniele Torella, Eleonora Cianflone

Summary: Diabetes mellitus affects the biology of cardiac stem/progenitor cells, inhibiting their regenerative potential. By clearing senescent cells, the function of these cells can be restored, resulting in improved cardiac function in diabetic patients.

DIABETES (2022)

Article Cell & Tissue Engineering

Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy

Robin Duelen, Domiziana Costamagna, Guillaume Gilbert, Liesbeth De Waele, Nathalie Goemans, Kaat Desloovere, Catherine M. Verfaillie, Karin R. Sipido, Gunnar M. Buyse, Maurilio Sampaolesi

Summary: This study utilized DMD patient-specific hiPSCs to model cardiomyopathy and uncovered the mechanism of oxidative stress in DMD cardiomyocytes. Targeting ROS production and preventing the detrimental effects of NOX4 on DMD CMs were proposed as promising therapeutic strategies.

STEM CELL REPORTS (2022)

Review Cell Biology

Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia

Laura Yedigaryan, Martina Gatti, Vittoria Marini, Tullia Maraldi, Maurilio Sampaolesi

Summary: Cachexia and sarcopenia are significant conditions involving muscle loss, which can lead to mortality and disability. MicroRNAs play a key role in the development of muscle wasting in both cachexia and sarcopenia. Understanding the epigenetic mechanisms related to muscle loss in these conditions can help identify potential therapeutic interventions.
Article Cell Biology

Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression

Vittoria Marini, Fabiola Marino, Flaminia Aliberti, Nefele Giarratana, Enrico Pozzo, Robin Duelen, Alvaro Cortes Calabuig, Rita La Rovere, Tim Vervliet, Daniele Torella, Geert Bultynck, Maurilio Sampaolesi, Yoke Chin Chai

Summary: In this study, cardiac organoids were generated from patient-derived induced pluripotent stem cells to model Duchenne Muscular Dystrophy (DMD)-related cardiomyopathy. The organoids exhibited progressive loss of sarcoglycan localization, endoplasmic reticulum stress, cardiomyocyte deterioration, fibrosis, and aberrant adipogenesis over time. RNA sequencing analysis identified distinct transcriptomic profiles and crucial miRNAs associated with DMD-related cardiomyopathy. These findings suggest the potential for developing in vitro 3D human cardiac-mimics to study DMD-related cardiomyopathies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell Biology

Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia

Domiziana Costamagna, Valerie Casters, Marc Beltra, Maurilio Sampaolesi, Anja Van Campenhout, Els Ortibus, Kaat Desloovere, Robin Duelen

Summary: This study generated in vitro human neuromuscular junctions (NMJs) using a microfluidic strategy from patient-specific induced pluripotent stem cell (hiPSC) lines to model disease-relevant neuropathologic processes in hereditary spastic paraplegia (HSP). The unique strength of this NMJ model is its ability to generate lower motor neurons (MNs) and myotubes from autologous hiPSC origin while maintaining the genetic background of HSP patient donors. The study found that HSP-derived lines exhibited axonal swellings, reduced levels of SPASTIN protein, and impaired NMJ profiles, offering unique tools to study the pathologic mechanisms of HSP.
Article Multidisciplinary Sciences

PGC-1α in the myofibers regulates the balance between myogenic and adipogenic progenitors affecting muscle regeneration

Marc Beltra, Fabrizio Pin, Domiziana Costamagna, Robin Duelen, Alessandra Renzini, Riccardo Ballaro, Lorena Garcia-Castillo, Ambra Iannuzzi, Viviana Moresi, Dario Coletti, Maurilio Sampaolesi, Fabio Penna, Paola Costelli

Summary: This study reveals that overexpression of PGC-1 alpha in myofibers alters the proportion of MuSCs and ISCs, leading to enhanced fusion of myogenic progenitors with recipient myofibers and reduced adipogenesis in skeletal muscle.

ISCIENCE (2022)

Article Cell Biology

Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2

Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H. Llewelyn Roderick, Maurilio Sampaolesi

Summary: Bcl-2 plays a crucial role in the differentiation of cardiomyocytes, and its loss delays the induction of pluripotent stem cells into cardiomyocytes, leading to reduced expression and activity of the cardiomyocyte Ca2+ toolkit, as well as decreased c-Myc expression and nuclear localization in the early phase of cardiac differentiation.

JOURNAL OF CELL SCIENCE (2023)

Article Immunology

Extracellular vesicle-derived miRNAs improve stem cell-based therapeutic approaches in muscle wasting conditions

Laura Yedigaryan, Ester Martinez-Sarra, Giorgia Giacomazzi, Nefele Giarratana, Bernard K. van der Veer, Alessio Rotini, Silvia Querceto, Hanne Grosemans, Alvaro Cortes-Calabuig, Sara Salucci, Michela Battistelli, Elisabetta Falcieri, Rik Gijsbers, Mattia Quattrocelli, Kian Peng Koh, Liesbeth De Waele, Gunnar M. Buyse, Rita Derua, Maurilio Sampaolesi

Summary: This study identifies an extracellular vesicle-derived miRNA signature that enhances the myogenic potential of myogenic stem cells, leading to improvements in muscle degeneration and muscle wasting related diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Review Genetics & Heredity

Mesoangioblasts at 20: From the embryonic aorta to the patient bed

Giulio Cossu, Rossana Tonlorenzi, Silvia Brunelli, Maurilio Sampaolesi, Graziella Messina, Emanuele Azzoni, Sara Benedetti, Stefano Biressi, Chiara Bonfanti, Laricia Bragg, Jordi Camps, Ornella Cappellari, Marco Cassano, Fabio Ciceri, Marcello Coletta, Diego Covarello, Stefania Crippa, M. Gabriella Cusella-De Angelis, Luciana De Angelis, Arianna Dellavalle, Jordi Diaz-Manera, Daniela Galli, Francesco Galli, Cesare Gargioli, Mattia F. M. Gerli, Giorgia Giacomazzi, Beatriz G. Galvez, Hidetoshi Hoshiya, Maria Guttinger, Anna Innocenzi, M. Giulia Minasi, Laura Perani, Stefano C. Previtali, Mattia Quattrocelli, Martina Ragazzi, Urmas Roostalu, Giuliana Rossi, Raffaella Scardigli, Dario Sirabella, Francesco Saverio Tedesco, Yvan Torrente, Gonzalo Ugarte

Summary: In 2002, we discovered a group of vessel-associated progenitors called mesoangioblasts (MABs). Studies over the past decade have shown that muscle development and regeneration are more complex than previously thought. We identified the origin of MABs as partly from the embryonic aorta and later from the microvasculature of skeletal muscle. MABs could be expanded in vitro and cross the vessel wall, making them a potential choice for cell therapy of muscular dystrophies.

FRONTIERS IN GENETICS (2023)

Article Biochemistry & Molecular Biology

Human Neuromuscular Junction on a Chip: Impact of Amniotic Fluid Stem Cell Extracellular Vesicles on Muscle Atrophy and NMJ Integrity

Martina Gatti, Katarina Stoklund Dittlau, Francesca Beretti, Laura Yedigaryan, Manuela Zavatti, Pietro Cortelli, Carla Palumbo, Emma Bertucci, Ludo van den Bosch, Maurilio Sampaolesi, Tullia Maraldi

Summary: Neuromuscular junctions are important for communication between spinal motor neurons and skeletal muscle, and their vulnerability in degenerative diseases like muscle atrophy is poorly understood. Recent studies have shown the regenerative potential of stem cells and extracellular vesicles in muscle fiber regeneration, but their role in counteracting NMJ perturbations is not clear. In this study, a co-culture system was used to investigate the effects of AFSC-derived EVs on NMJ alterations induced by muscle atrophy. The presence of EVs reduced morphological and functional defects and prevented oxidative stress in atrophic myotubes. This study provides a valuable tool for studying MN and myotube interactions and demonstrates the efficacy of AFSC-EVs in counteracting NMJ perturbations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Physiology

Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression

Laura Yedigaryan, Maurilio Sampaolesi

Summary: Duchenne muscular dystrophy (DMD) is a severe disorder caused by mutations in the dystrophin gene, leading to muscle fiber degradation and weakness. Extracellular vesicles (EVs), secreted by cells, may play a role in DMD pathology and could serve as biomarkers for specific pathological processes. Additionally, EVs can be used for targeted cargo delivery and inhibition of EV secretion, providing potential therapeutic strategies for DMD.

FRONTIERS IN PHYSIOLOGY (2023)

Article Cell Biology

Ex vivo adult stem cell characterization from multiple muscles in ambulatory children with cerebral palsy during early development of contractures

M. Corvelyn, J. Meirlevede, J. Deschrevel, E. Huyghe, E. De Wachter, G. Gayan-Ramirez, M. Sampaolesi, A. Van Campenhout, K. Desloovere, D. Costamagna

Summary: Cerebral palsy (CP) is a common condition causing lifelong physical disability in children. Previous studies have shown changes in muscle properties, such as decreased number of satellite cells and altered fusion capacity. However, these observations vary widely among studies, possibly due to differences in patient population, lack of control data, methodology, and muscle assessment. This study aimed to further investigate CP muscle pathology and confirm previous findings of increased satellite cell fusion capacity.

DIFFERENTIATION (2023)

Article Cell Biology

Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions

Domiziana Costamagna, Valeria Bastianini, Marlies Corvelyn, Robin Duelen, Jorieke Deschrevel, Nathalie De Beukelaer, Hannah De Houwer, Maurilio Sampaolesi, Ghislaine Gayan-Ramirez, Anja Van Campenhout, Kaat Desloovere

Summary: This study aims to clarify the impact of BoNT on growing muscles by analyzing the effect of BoNT on muscle stem cells in vitro, and by following the effect of in vivo BoNT administration on these cells obtained from children with CP. The results show that in vitro BoNT does not affect muscle differentiation or collagen production, but it does affect neuromuscular junctions. Further studies are needed to understand the long-term and collateral effects of BoNT in the muscles of children with CP.
暂无数据